Peter Lauer

A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis

John N. Feder, Andreas Gnirke, Zenta Tsuchihashi et al. · Nature Genetics · 1996 · 3.7K citations

Life Sciences, Genetics, Molecular Genetics +12

TOX is a critical regulator of tumour-specific T cell differentiation

Andrew Scott, Friederike Dündar, Paul Zumbo et al. · Nature · 2019 · 1.1K citations · Full text

Life Sciences, Immunology, Oncology +14

Chromatin states define tumour-specific T cell dysfunction and reprogramming

Mary Philip, Lauren Fairchild, Liping Sun et al. · Nature · 2017 · 916 citations · Full text

Life Sciences, Cancer Biology, Oncology +14

Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis

Andrea Schietinger, Mary Philip, Varintra E. Krisnawan et al. · Immunity · 2016 · 726 citations · Full text

Life Sciences, Immunology, Oncology +14

STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade

Juan Fu, David B. Kanne, Meredith L. Leong et al. · Science Translational Medicine · 2015 · 700 citations

Medicine, Oncology, Pharmacology +16